Cryo Cell International (CCEL) Total Non-Current Liabilities (2016 - 2026)
Cryo Cell International's Total Non-Current Liabilities history spans 17 years, with the latest figure at $79.2 million for Q1 2026.
- Quarterly results put Total Non-Current Liabilities at $79.2 million for Q1 2026, up 264.79% from a year ago — trailing twelve months through Feb 2026 was $79.2 million (up 264.79% YoY), and the annual figure for FY2025 was $19.8 million, down 74.57%.
- Total Non-Current Liabilities for Q1 2026 was $79.2 million at Cryo Cell International, up from $19.8 million in the prior quarter.
- In the past five years, Total Non-Current Liabilities ranged from a high of $79.2 million in Q1 2026 to a low of $17.4 million in Q3 2024.
- The 5-year median for Total Non-Current Liabilities is $50.0 million (2022), against an average of $45.7 million.
- The sharpest move saw Total Non-Current Liabilities tumbled 74.67% in 2024, then skyrocketed 347.43% in 2025.
- Year by year, Total Non-Current Liabilities stood at $19.5 million in 2022, then rose by 7.1% to $20.9 million in 2023, then soared by 273.11% to $77.8 million in 2024, then plummeted by 74.57% to $19.8 million in 2025, then soared by 300.33% to $79.2 million in 2026.
- According to Business Quant data, Total Non-Current Liabilities over the past three periods came in at $79.2 million, $19.8 million, and $78.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.